Next Quarterly Earnings
Thursday, October 22, 2026
CW 43
Pre-Market
In 56 days
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Novocure
Novocure is an innovative oncology company dedicated to developing Tumor Treating Fields (TTFields). This unique electrotherapy targets solid tumors, particularly glioblastomas and mesotheliomas. Novocure enhances cancer therapy and patient quality of life globally through cutting-edge medical devices.
Frequently asked questions
When will Novocure report its next quarterly earnings?
Novocure is scheduled to report its next quarterly earnings on 10/22/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
When did Novocure last report quarterly earnings?
Novocure last reported quarterly earnings on 7/23/2026 (Q2 2026). Earnings per share (EPS) came in at -0.13 USD.
How does Novocure stock react to earnings?
Across its last 3 earnings reports, Novocure stock moved by ±13.6% on average the following day. The largest reaction was +27.5% on 04/30/2026; 1 of 3 reactions were positive.
How often has Novocure beaten expectations?
Novocure has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
How do I add the Novocure earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±13.6%
Avg. next-day move
+27.5%
Largest move (04/30/2026)
33.3%
Share of positive reactions
±20.8%
Avg. move after 7 days
Basis: price reactions to the last 3 report dates (close to close).
Estimates vs. results
4/5
Quarters above estimates
80%
Beat rate
+17.3%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Novocure
Country
🇬🇧
More Financial Information